Patent · US Active

Generation of a mesenchymal stromal cell bank from the pooled mononuclear cells of multiple bone marrow donors

US10472608B2 · kind B2 · utility

11Cited by
1References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 14, 2015
Grant dateNov 12, 2019
Priority date
Expiry dateJul 14, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2035/124
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention pertains to an improved mesenchymal stromal cell (MSC) preparation and a method for producing the same. The invention provides a new strategy to isolate MSC from bone marrow mononuclear cells (BM-MNCs) by pooling BM-MNCs of multiple unrelated (third-party) bone marrow donors. The MSC preparation manufactured in accordance with the methodology of the invention is characterized by a stable proliferative capability and an increased immunosuppressive potential when compared to individual donor MSC preparations or a pool of individual MSCs generated from multiple donors. The MSCs prepared ac- cording to the invention are particularly useful for medical applications such as the treatment of graft-versus-host disease (GvHD) in recipients with hematopoietic stem cell transplants, patients with autoimmune disorders and as a cell-based therapy in regenerative medicine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.